Currently predicting for Thu, 4 Jun 2026

CGEN Prediction Chart

CGEN Predictions History

Latest community submissions for CGEN.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 24, 2022 $0.725 -12.69% $0.80 V 90.58% 1
Oct 24, 2022 Bullish $0.80 X 0
JS JS Pro
Jun 27, 2022 $2.03 -2.87% $1.94 V 95.36% 1
Jun 27, 2022 $2.15 +2.87% $1.94 X 89.18% 0
JS JS Pro
Nov 26, 2021 $4.67 +2.86% $4.54 X 97.14% 0
Nov 26, 2021 $4.71 +3.74% $4.54 X 96.26% 0
Bi Cheng Bi Cheng @BiCheng.222158
Mar 9, 2021 Bullish $8.52 X 1
Mar 9, 2021 $7.21 -15.38% $8.52 X 84.62% 0
JS JS Pro
Feb 25, 2021 $10.60 +18.30% $8.96 X 81.70% 0
Kevin Ripper Kevin Ripper @KevinRipper.214730
Feb 25, 2021 $11.36 +26.79% $8.96 X 73.21% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CGEN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COMPUGEN LTD.
Compugen
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE